Istanbul — SIRA GROUP has completed its annual portfolio review for 2025, covering each operating company and every investment position held at the project or division level.

The review confirmed the group’s four operating divisions — real estate, healthcare, consulting and hospitality — and the priorities for the year ahead: the delivery of Sira Prime, the PET-CT wing at Rosina Diagnostic Center, the East Africa market-entry programme, and the formation of the hospitality platform. No position was exited during the year.

Investors in the group’s opportunities receive the full review with their fourth-quarter reporting. Enquiries may be directed to investor relations.